SCHEMBL8124385

SCHEMBL8124385

Nc1cc2nc(N)c(-c3ccccc3Cl)cc2cn1

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 10/20 0.74
SRC P12931 8/20 0.74
PDPK1 O15530 1/20 0.43
BACE1 P56817 1/20 0.42
MAP4K4 O95819 1/20 0.42
KDR P35968 1/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40
ABL1 P00519 1/20 0.40
USP7 Q93009 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
LIMK1 P53667 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8134775 0.85 FGFR1 (1.00) FGFR1SRCKDR
SCHEMBL8807633 0.85 FGFR1 (1.00) FGFR1SRCKDR
SCHEMBL8134814 0.82 FGFR1 (0.66) FGFR1SRCPDPK1BACE1KDR
SCHEMBL11115455 0.74 FGFR1 (0.55) FGFR1SRCMAP4K4USP7ADORA2A
SCHEMBL18227070 0.74 TERT (0.49) FGFR1SRCBACE1HSP90AA1HSP90AB1
SCHEMBL4500154 0.71 PLA2G7 (0.53) FGFR1SRCPDPK1BACE1MAP4K4
SCHEMBL14244969 0.71 ABL1 (0.63) FGFR1SRCPDPK1BACE1KDR
SCHEMBL1517012 0.71 ADORA1 (0.47) FGFR1SRCPDPK1KDRHSP90AA1
SCHEMBL4186547 0.70 DHFR (0.56) FGFR1SRCHSP90AA1HSP90AB1ADORA2A
SCHEMBL15488575 0.70 CHRM5 (0.48) FGFR1SRCMAP4K4USP7HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790997-B1 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2000-03-22 EP claimed
US-5952342-A 1,6-NAPHTHYRIDINES EFFECTIVE IN TREATING ATHEROSCLEROSIS, RESTENOSIS AND PSORIASIS; ANTICARCINOGENIC AND -PROLIFERATIVE AGENTS; BACTERICIDES WARNER-LAMBERT COMPANY (US) 1999-09-14 US claimed
EP-0790997-A2 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1997-08-27 EP claimed
WO-1996015128-A2 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-05-23 WO claimed
CN-1085666-C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyrosine kinase medicated cellular proliferation WARNER LAMBERT CO (US) 2002-05-29 CN disclosed
EP-0790997-B1 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2000-03-22 EP disclosed
US-5952342-A 1,6-NAPHTHYRIDINES EFFECTIVE IN TREATING ATHEROSCLEROSIS, RESTENOSIS AND PSORIASIS; ANTICARCINOGENIC AND -PROLIFERATIVE AGENTS; BACTERICIDES WARNER-LAMBERT COMPANY (US) 1999-09-14 US disclosed
US-5733913-A TREATING ATHEROSCLEROSIS, POSTSURGICAL RESTENOSIS WARNER-LAMBERT COMPANY 1998-03-31 US disclosed
CN-1169726-A 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyrosine kinase medicated cellular proliferation WARNER LAMBERT CO (US) 1998-01-07 CN disclosed
EP-0790997-A2 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1997-08-27 EP disclosed
WO-1996015128-A2 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-05-23 WO disclosed